Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
26-29 March, 2025
Not Confirmed
Not Confirmed
27-29 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
26-29 March, 2025
Industry Trade Show
Not Confirmed
27-29 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
04 Mar 2022
// P. Schloesser ENDPTS
https://endpts.com/after-buying-out-flexion-for-450m-pacira-quietly-laid-off-110-of-its-employees/
12 Oct 2021
// Angus Liu FIERCEPHARMA
https://www.fiercepharma.com/pharma/pacira-boosts-non-opioid-pain-portfolio-via-450m-flexion-buy-more-cvr-payments-to-come
11 Oct 2021
// Madeleine Armstrong EVALUATE
https://www.evaluate.com/vantage/articles/news/deals/supernus-and-pacira-swoop-while-their-targets-are-down
01 Oct 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2021/10/01/2307364/29848/en/Flexion-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
02 Sep 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2021/09/02/2290770/29848/en/Flexion-Therapeutics-Announces-Inclusion-of-ZILRETTA-in-American-Academy-of-Orthopaedic-Surgeons-AAOS-Clinical-Practice-Guidelines-for-the-Management-of-Osteoarthritis-of-the-Knee.html
25 Aug 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2021/08/25/2286225/29848/en/Flexion-Therapeutics-Announces-Expansion-of-Phase-1b-Trial-Investigating-FX301-for-the-Management-of-Post-Operative-Pain.html
ABOUT THIS PAGE